학술논문

Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm Trial
Document Type
Article
Source
In: JAMA network open. (JAMA network open, 1 February 2023, 6(2):e2255758)
Subject
Language
English
ISSN
25743805